Apollo-backed Novolex and Pactiv Evergreen to merge in $6.7bn deal

The deal is supported by Apollo, the majority shareholder of Novolex since 2022, and Canada Pension Plan Investment Board.

10 December 2024•2 mins read
LinkedInXEmail
LinkedInXEmail

Related articles